CoLucid Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire CoLucid Pharmaceuticals, Inc.
Quantité totale PI 14
Rang # Quantité totale PI 112 262
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 349 356
Parent Eli Lilly and Company. As of February 28, 2017, CoLucid Pharmaceuticals, Inc. operates as a subsidiary of Eli Lilly and Company
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 0
2 1
7 0
0
 
Dernier brevet 2025 - Composition of 2,4,6-trifluoro-n...
Premier brevet 2004 - Carbamoyl esters that inhibit ch...
Dernière marque 2016 - EXGEMIG
Première marque 2016 - EXGEMIG

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide. The...
2021 Invention Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl[-benzamide. The ...
2017 Invention 1f agonists. The present invention provides new pseudo-polymorphs of the hemisuccinate salt of 2,...
Invention Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists. The present invention p...
2016 P/S Pharmaceutical preparations for human use for the treatment of central nervous system disorders, ...
2011 Invention Compositions and methods of synthesis of pyridinolypiperidine 5-ht1f agonists. The present invent...
Invention Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists. The present invent...
Invention Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents. Carbam...
2010 Invention Composition of 2,4,6- trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide. Th...
Invention Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide. The ...
Invention Compositions of cholinesterase inhibitors. The present invention is directed to compositions, me...
Invention Compositions of cholinesterase inhibitors. The present invention is directed to compositions, met...
2009 Invention Stigmine conjugates for substance use disorders. The invention relates to methods for the treatm...
Invention Stigmine conjugates for substance use disorders. The invention relates to methods for the treatme...
2008 Invention Methods for promoting wakefulness. The present invention relates to methods of promoting wakeful...
Invention Methods for promoting wakefulness. The present invention relates to methods of promoting wakefuln...
Invention Compounds that inhibit cholinesterase. Compounds that inhibit cholinesterase activity and, upon h...
2004 Invention Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents. Carbamo...